Autonomix (AMIX) Medical announced the next CEO Corner segment has been published on the Company’s website. For the CEO Corner segment, Brad Hauser, CEO of Autonomix, elaborates on the Company’s recently announced planned follow-on market expansion study phase of its proof-of-concept trial.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMIX:
- Autonomix announces first patient enrolled, treated in follow-on phase to POC 2
- Autonomix granted U.S. patent for catheter-based platform technology
- Autonomix granted approval to expand PoC human clinical trial
- Autonomix granted key U.S. patent for catheter-based platform technology
- Autonomix CEO outlines follow-on expansion study expected to begin in Q2